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Recently, the spin-echo full-intensity acquired localized (SPE-
CIAL) spectroscopy technique was proposed to unite the ad-
vantages of short TEs on the order of milliseconds (ms) with full
sensitivity and applied to in vivo rat brain. In the present study,
SPECIAL was adapted and optimized for use on a clinical plat-
form at 3T and 7T by combining interleaved water suppression
(WS) and outer volume saturation (OVS), optimized sequence
timing, and improved shimming using FASTMAP. High-quality
single voxel spectra of human brain were acquired at TEs below
or equal to 6 ms on a clinical 3T and 7T system for six volun-
teers. Narrow linewidths (6.6  0.6 Hz at 3T and 12.1  1.0 Hz at
7T for water) and the high signal-to-noise ratio (SNR) of the
artifact-free spectra enabled the quantiﬁcation of a neuro-
chemical proﬁle consisting of 18 metabolites with Crame´r-Rao
lower bounds (CRLBs) below 20% at both ﬁeld strengths. The
enhanced sensitivity and increased spectral resolution at 7T
compared to 3T allowed a two-fold reduction in scan time, an
increased precision of quantiﬁcation for 12 metabolites, and the
additional quantiﬁcation of lactate with CRLB below 20%. Im-
proved sensitivity at 7T was also demonstrated by a 1.7-fold
increase in average SNR ( peak height/root mean square [RMS]-
of-noise) per unit-time. Magn Reson Med 61:1279–1285, 2009.
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Stimulated-echo acquisition mode (STEAM) (1) or point-
resolved spectroscopy (PRESS) (2) are the major methods
used for localized proton magnetic resonance spectros-
copy (MRS). As STEAM suffers a two-fold signal loss
compared to PRESS, but allows shorter echo times (TEs), it
is highly desirable to combine the short TE achievable
with STEAM with the full signal intensity provided by
PRESS. In general, short echo times below 20 ms offer the
beneﬁts of reduced signal decay due to T2 relaxation and
J-evolution of coupled spin systems. This in turn allows a
more precise quantiﬁcation of metabolites including those
with short T2 relaxation times. In addition, signal contri-
butions from macromolecules that generally exhibit short
T2s can be analyzed in short TE spectra to provide insight
into speciﬁc diseases (3). Short echo times are more easily
achievable with STEAM because of the lower peak radio-
frequency (RF) pulse power requirements for 90° com-
pared to 180° pulses. This is especially important for stud-
ies in humans, where the available peak RF power is
limited. The STEAM technique was extensively used in
previous studies to acquire human brain spectra at ﬁeld
strengths of 1.5T, 3T, 4T, and 7T using TE  5 ms (4) and
6 ms (5), 6.8 ms (6), 4 ms (7), and 6 ms (8), respectively.
On the other hand, it is advantageous to acquire the
signal of the full magnetization using spin-echo (SE)-based
methods, such as PRESS. For the aforementioned reasons,
only few studies report results acquired at short TE. Re-
ducing crusher gradients and using short RF pulses in one
approach, or utilizing a dedicated transmit/receive head
coil at 3T in pediatric patients in another approach, en-
abled PRESS acquisitions of in vivo human single-voxel
spectroscopy (SVS) data at TE  10 ms (9,10). Using the
proton echo-planar spectroscopic imaging technique, a TE
of 15 ms was reported in MR spectroscopic imaging
(MRSI) at 3T and 4T (11).
The advantages of short TEs on the order of milliseconds
(ms) were recently combined with full signal intensity
achieved with SE-based scans using the SE full intensity
acquired localized (SPECIAL) spectroscopy technique and
applied to in vivo rat brain (12). The sequence beneﬁts
from RF coils producing strong B1 ﬁelds and combines
interleaved water suppression (WS) and outer volume sat-
uration (OVS), optimized sequence timing, and improved
localized shimming. Moreover, the application of SPE-
CIAL at high B0 ﬁelds (3T) sought to take advantage of
the corresponding increased sensitivity and increased
spectral resolution, particularly at 7T, where so far only
few in vivo human MRS studies at short TE using STEAM
have been conducted on experimental scanners (8).
Therefore, the aim of this study was to implement and
optimize SPECIAL on a clinical platform at 3T and at 7T
and to obtain high-quality single-voxel spectra of the hu-
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man brain at ultrashort TEs (10 ms). In addition, an
initial comparison of the results obtained at the two dif-
ferent ﬁeld strengths was performed in terms of signal-to-
noise ratio (SNR) and reliability of metabolite quantiﬁca-
tion.
MATERIALS AND METHODS
All scans were performed on a 90-cm bore clinical 3T
(Magnetom Trio, a Tim System, Syngo MR VB15) scanner
equipped with a whole-body gradient coil (40 mT/m, 200
mT/[mms]) and an actively-shielded 7T (Tim System,
Syngo MR VB15) human head system of 68-cm bore with
a head gradient coil (60 mT/m, 330 mT/[mms]) (Siemens
Medical Solutions, Erlangen, Germany). On both systems,
a quadrature transmit (Tx)/receive (Rx) surface RF coil
consisting of two decoupled single-turn coils of 13-cm-
diameter was used (13). At 3T, data were also acquired
using a transverse electromagnetic (TEM) volume coil (14)
(MR Instruments, Inc., Minneapolis, MN, USA).
Pulse Sequence
SPECIAL (12) combines an one-dimensional (1D) image-
selected in vivo spectroscopy (ISIS) (15) approach with a
slice-selective SE sequence (see Fig. 1). Full localization
was accomplished by using an add-subtract scheme,
where the signal was added in odd scans and subtracted in
even scans corresponding to the application of an adia-
batic inversion pulse. The implementation of SPECIAL
was adapted and optimized for a clinical platform as fol-
lows: due to the reduced peak RF power and gradient
strengths, all settings and durations of RF pulses and gra-
dients were readjusted and calibrated. Water signal sup-
pression was achieved using variable-pulse power and
optimized relaxation delays (VAPOR) (16) plus an addi-
tional Gaussian WS pulse that was executed after the adi-
abatic inversion pulse (see Fig. 1). The bandwidth of the
Gaussian WS pulses was set to 45 Hz at 3T and to 60 Hz at
7T to account for different linewidths and chemical shift
dispersions at the two B0 ﬁelds. The VAPOR WS scheme
was interleaved with multiple blocks of OVS to reduce
contaminating signals originating from extracranial lipids.
Timing and delays of this interleaved sequence module
were separately adjusted for the two ﬁeld strengths based
on approaches described in (7). Hyperbolic-secant RF
pulses with 5.0-ms duration, an 8.4 kHz bandwidth, a peak
B1 amplitude (/2B1max) of 0.75 kHz, and a nominal ﬂip
angle of 90° were used for OVS to minimize chemical shift
artifacts. In addition, each hyperbolic-secant RF pulse was
also executed with a RF transmitter voltage that was in-
creased by a factor of the square root of 2 to improve the
effectiveness of the OVS in the presence of a spatially
inhomogeneous B1 ﬁeld. For inversion, a hyperbolic-se-
cant RF pulse with TPulse  5.12 ms, BWRF  2.1 kHz, and
(/2B1max)  0.75 kHz was employed. Large B1 peak
amplitudes and the use of an asymmetric RF excitation
pulse in the SPECIAL method allowed ultrashort echo
times (TEmin  3.5 ms at 3T and 5.5 ms at 7T). To obtain a
typical TE  6 ms, TPulse  1.28 ms with BWRF  5.3 kHz
and (/2B1max)  1.3 kHz and TPulse  3.2 ms with
BWRF  1.8 kHz and (/2B1max)  1.7 kHz were used for
the asymmetric RF excitation (16) and for the symmetric
refocusing pulse introduced by Mao et al. (17), respec-
tively. Spoiler gradients were inserted to dephase any
potential transverse magnetization.
Data Acquisition and Metabolite Quantiﬁcation
For data acquisition, a volume-of-interest (VOI) in the
occipital lobe was selected using T1-weighted (3T) or T*2-
weighted (7T) gradient echo (GRE) scout images. Each
volunteer was scanned on both systems, and placement of
the VOI was the same based on anatomical landmarks for
both scans and also across volunteers. In addition to a
localized calibration of RF transmitter voltages for the
selected VOI, ﬂip angles of the WS pulses were optimized
for each individual subject, and position and size of the
OVS bands were slightly adapted interactively according
to voxel location. First- and second-order shims were ad-
justed using a fully adiabatic version of FASTMAP/FAST-
ESTMAP (18,19). After concluding all adjustment proce-
dures, 1H single-volume acquisitions of the human brain
were performed using the following scan parameters:
VOI 20 20 20 mm3, TR/TE 4000 ms/6 ms, spectral
width  2 kHz (3T) or 4 kHz (7T), number of averages
(NA)  128 (3T) or 64 (7T), vector size  2048, delta of
excitation frequency (fexc)  –2.3 ppm (i.e., the reference
frequency used for calculating offsets of slice-elective RF
pulses was shifted 2.3 ppm upﬁeld from the water reso-
nance). Data were acquired for N  6 volunteers aged
22–26 years. Spectral quality was such that neither eddy
current postprocessing, nor water removal, nor baseline
correction was necessary or applied. The spectra were
quantitatively analyzed using LCModel (20) with basis sets
for the two different ﬁeld strengths created by quantum
mechanics simulations. For the 3T data, a set of macro-
FIG. 1. Schematic of the SPECIAL pulse sequence. The ﬁrst 180°
pulse is adiabatic and is applied in alternate scans, together with
alternating the phase of the receiver. WS represents an additional
water saturation pulse.
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molecules was provided by LCModel, whereas for the 7T
spectra an experimentally acquired set of macromolecules
was used. The LCModel analysis was carried out on spec-
tra for chemical shifts in the range of 0.2 to 4.2 ppm.
Results from metabolite quantiﬁcation for 3T and 7T data
were compared, and differences were statistically evalu-
ated using the t-test.
RESULTS
Ultrashort TE 1H SVS data from the human brain were
acquired at 3T (Fig. 2) and at 7T (Fig. 3). Peaks of glu-
tamine (Gln) and glutamate (Glu) were clearly resolved at
both ﬁelds. Baseline distortions that might be visible in
ultrashort TE spectra were not observed. Comparing the
two spectra in Fig. 2 and Fig. 3, it is noted that the in-
creased spectral resolution at 7T due to increased chemi-
cal shift dispersion and generally simpliﬁed J-coupling
patterns yields an increased number of resolved spectral
features, such as the doublet of aspartate (Asp) at 2.80 ppm
and the triplet of -aminobutric acid (GABA) at 2.28 ppm,
and an improved separation of spectral lines of individual
metabolites, such as Gln and Glu or Scyllo-inositol
(Scyllo) and taurine (Tau). Reproducibly across volun-
teers, the obtained data showed excellent WS, especially at
7T, as seen in Fig. 2 and Fig. 3. In all cases, the residual
signal of water was smaller than the singlet of N-acetylas-
partate (NAA) at 2.01 ppm. In addition, the lipid contam-
ination was sufﬁciently suppressed by the application of
OVS illustrated by the consistently artifact-free region of
the spectra around 1.3 ppm (Figs. 2 and 3). Localized
shimming using FASTMAP/FASTESTMAP resulted in
water linewidths measured as full-linewidth at half-max-
imum (FWHMH2O) ranging from 6.0 to 7.5 Hz with a mean
FWHMH2O  6.6  0.6 Hz in gray matter (GM)-rich regions
of the occipital lobe at 3T. At 7T, FWHMH20 in the range of
10.9 to 13.5 Hz with a mean FWHMH20  12.1  1.0 Hz
were obtained in similar voxel locations. Using the SPE-
CIAL acquisition scheme at ultrashort TEs resulted in a
high SNR. The ultrashort TEs reduced signal attenuation
due to T2 relaxation as well as modulation of J-coupled
multiplets. The average SNR, i.e., the maximum peak-
height, which in this case corresponded to the height of
the NAA peak at 2.01 ppm, divided by the root mean
square (RMS) of residual (unﬁtted) noise, calculated by
LCModel analysis was 64.8  3.1 at 3T and 76.5  5.2 at
7T. Considering that the spectra at 7T were acquired in
one-half the scan time, the ratio of the average SNR per
unit-time between the two ﬁeld strengths was calculated to
be 1.7.
An example for data acquired with a TEM volume coil
from a VOI in parietal white matter is presented in Fig. 4.
In this case, FWHMH20 was 6.2 Hz, and a SNR of 48 was
calculated. Spectral quality was similar to the one of the
data shown in Fig. 2 including the absence of lipid con-
taminations. With respect to data quality this example was
representative for several different acquisitions performed
with the TEM volume coil.
Metabolite Quantiﬁcation
Figure 5 shows the corresponding ﬁtted curves using LC-
Model for the 1H spectra displayed in Fig. 2 and in Fig. 3.
At both ﬁeld strengths, analysis using LCModel yielded
excellent ﬁts of the spectra illustrated by the small resid-
uals included directly below the respective LCModel ﬁt of
FIG. 2. 1H NMR spectrum from a GM-rich VOI 20 20 20 mm3
in the occipital lobe of a volunteer acquired with an optimized
SPECIAL acquisition scheme at 3T. TR/TE  4000 ms/6 ms, NA 
128, and BW  2 kHz. Data processing consisted of zero-ﬁlling up
to 8-k data points, 1 Hz Gaussian weighting of the free induction
decay (FID), Fourier transformation, and phase correction. Note the
excellent data quality of the artifact-free spectrum. Inset: transverse
T1-weighted GRE image with the location of the VOI.
FIG. 3. 1H NMR spectrum from the occipital lobe of the same
volunteer as shown in Fig. 2 acquired with SPECIAL at 7T using the
same scan parameters, except for NA  64 and BW  4 kHz. Data
processing was the same as for Fig. 2, except for a 2-Hz Gaussian
weighting of the faster-decaying FID at 7T. Comparing the spectrum
with the data presented in Fig. 2, the increased spectral resolution
at the higher ﬁeld becomes apparent. Inset: transverse T *2-weighted
GRE image with the location of the VOI.
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each spectrum in Fig. 5a and b. Metabolite linewidths
determined from the singlet of creatine (Cr) at 3.03 ppm
were estimated as 4.3  0.2 Hz and 8.5  0.9 Hz at 3T and
7T, respectively. Resulting absolute metabolite concentra-
tions together with their respective Crame´r-Rao lower
bounds (CRLBs) were compared for 18 metabolites at both
ﬁelds, which had average CRLBs below 20% (Table 1; not
including lactate (Lac) and glucose (Glc)). The CRLB aver-
aged over all these metabolites was 35% lower at 7T than
at 3T, which was signiﬁcant (P  0.015). For 12 metabo-
lites the CRLB was on average reduced by 38%, and for six
metabolites it was approximately equal. A substantial im-
provement in CRLB was observed at 7T for Gln, Tau, and
Gln	Glu. Moreover, Lac was additionally quantiﬁed with
CRLB below 20% at the higher ﬁeld, yielding a concentra-
tion of 0.7  0.1 mmol/kg with CRLB of 9  1.6%. In
contrast, the concentration of Glc was more reliably deter-
mined at 3T as 1.4  0.3 mmol/kg with a CRLB of 14 
2.7%. The average difference between metabolite concen-
trations determined at both ﬁelds was 2%, which was not
signiﬁcant (P
 0.22). Differences in concentrations for the
metabolites shown in Table 1 were within 15%, except for
phosphocreatine (PCr), GABA, Gln, and Scyllo.
FIG. 4. 1H NMR spectrum from a VOI  20  20  20 mm3 in the
parietal white matter of a volunteer acquired with an optimized
SPECIAL acquisition scheme at 3T using a TEM volume head coil.
TR/TE  2000 ms/6 ms, NA  256, and BW  2 kHz. Data pro-
cessing was the same as in Fig. 2. Data quality was similar to the
one of the spectra shown in Fig. 2, except for a slightly reduced SNR
as is expected from the use of a volume coil. Inset: transverse
T *2-weighted GRE image with the location of the VOI.
FIG. 5. Fitted curves using LCModel for the human brain spectra acquired at (a) 3T (see Fig. 2) and (b) 7T (see Fig. 3) for the range of 0.2
to 4.2 ppm. Note the excellent agreement between the data (“meas”) and the ﬁt (“ﬁt”) also illustrated by the small ﬁt residual (“res”) seen
below each ﬁt. In addition, LCModel output for metabolite signals (Table 1), macromolecule contributions, and baseline are shown for each
spectrum.
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DISCUSSION
Ultrashort TE spectra of high quality were obtained at 3T
and 7T using an optimized implementation of the SPE-
CIAL spectroscopy technique on a clinical platform. Full
signal from PRESS and short TEs from STEAM are united
in the SE-based SPECIAL method. The adaptation of the
pulse sequence for the two ﬁeld strengths yielded excel-
lent suppression of water signal and lipid contamination.
Eddy current postprocessing was not applied, despite the
use of gradients of large amplitudes to achieve ultrashort
TEs, as no distortion of line shapes was observed. En-
hanced localized shimming resulted in improved static
magnetic ﬁeld homogeneity, which is crucial for separat-
ing (partially) overlapping resonances and to take advan-
tage of the increased spectral resolution and SNR at higher
B0. The linewidths obtained at 7T in this study were com-
parable with those previously reported (8), in which an
experimental scanner was used. Adapting the implemen-
tation of SPECIAL from rat (12) to human brain applica-
tions yielded an increase in TE comparable to what was
observed with STEAM (8,16). Nevertheless, the advan-
tages of the SPECIAL technique (12) were retained: only
one RF refocusing pulse was used, which reduced RF
power requirements and improved chemical shift dis-
placement errors. Compared to PRESS, this also makes the
sequence less sensitive to B1 ﬁeld variations. In addition,
signal loss was further minimized by achieving a homoge-
neous inversion of the magnetization in the selected VOI
through the use of an adiabatic inversion pulse, even in the
presence of a spatially varying B1 ﬁeld. In contrast, imper-
fect inversion (and/or rapid T1 relaxation) would lead to
signal reduction. Transmitter voltages for RF pulses were
on average by a factor of 2.1 higher at 7T compared to 3T,
corresponding to a four-fold increase in RF power at the
higher ﬁeld.
It should be noted that volume selection performed with
a 1D ISIS approach that is utilized in SPECIAL can be more
susceptible to subject motion, frequency shifts (e.g., due to
breathing), and possible scanner instability compared to
standard single-shot acquisition techniques, such as
STEAM and PRESS. On the other hand, in SPECIAL the
sensitivity to motion is highly reduced through the appli-
cation of OVS prior to excitation by nulling the signal from
tissues surrounding the VOI. As a consequence, no data
degradation due to motion or possible frequency shifts was
observed in this study that included the data acquired
with the TEM volume coil at 3T (Fig. 4).
In general, using the same RF coil and receiver chain,
the SE-based SPECIAL sequence should provide an almost
two-fold increase in sensitivity over the STEAM sequence
at the same short echo times (12). A reliable quantiﬁcation
of a large number of metabolites at both ﬁeld strengths was
possible, which was attributed to a high SNR in combina-
tion with small FWHMs. The observed ratio of the average
SNR per unit-time between the two ﬁeld strengths was 1.7.
Considering the almost two-fold (1.97) increase in metab-
olite FWHM at 7T, this was slightly above the expectation
of a linear increase in sensitivity with ﬁeld strength (21),
since the product of 1.7 with 1.97 gives a factor of 3.3,
which is somewhat larger than the expected value of 7/3,
even when considering experimental error. Deviations
from theory are probably due to minor differences in voxel
positioning on the two systems in the sensitive volume of
the surface coils and to small residual peaks, which are
Table 1
Metabolite Quantiﬁcation of 1H Human Brain Spectra Acquired at 3T and 7T*
Metabolite
3T (NA  128) 7T (NA  64)
Concentration
(mmol/kg)
CRLB
(%)
Concentration
(mmol/kg)
CRLB
(%)
Asp 3.1  0.3 7  0.8 2.9  0.5 7  1.3
Cr 5.8  0.2 4  0.5 5.0  0.3 3  0.0
PCr 2.2  0.19 8  0.6 3.0  0.3 5  0.5
GABA 2.5  0.4 8  1.2 1.3  0.15 7  1.0
Gln 1.6  0.4 13  4.4 2.2  0.4 4  1.1
Glu 8.9  0.9 3  0.5 9.9  0.9 1  0.5
GSH 1.4  0.11 6  0.5 1.3  0.2 4  0.5
Ins 5.3  0.6 4  0.5 5.7  0.5 2  0.0
Lac — — 0.7  0.1 9  1.6
NAA 11.2  0.8 2  0.5 11.8  0.2 1  0.0
Scyllo 0.4  0.11 8  2.1 0.3  0.12 10  3.9
Tau 1.4  0.5 17  9.9 1.5  0.3 7  2.3
Glc 1.4  0.3 14  2.7 — —
NAAG 1.0  0.2 11  2.2 1.1  0.4 8  3.8
PE 2.2  0.18 8  0.6 2.5  0.3 5  0.5
GPC	PCho 1.1  0.13 3  0.4 1.1  0.05 3  0.5
NAA	NAAG 12.3  0.9 2  0.4 12.9  0.4 1  0.0
Ins	Gly 6.2  0.6 2  0.4 6.0  0.4 2  0.0
Cr	PCr 8.0  0.3 1  0.5 8.0  0.4 1  0.0
Glu	Gln 10.5  1.2 3  0.0 12.1  1.2 1  0.5
*Absolute concentrations and CRLBs are given as mean values  SDs for N  6 volunteers (for CRLBs below 20%). For calculating
“absolute” concentrations, the value of 8 mmol/kg was considered as the mean concentration of total creatine (tCr  Cr 	 PCr).
CRLB  Crame´r-Rao lower bound.
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visible in the “residuals” provided by LCModel (Fig. 5).
These peaks do not represent real noise and might differ
for simulations with different spectral basis sets at 3T and
7T. Using a spherical doped water phantom and acquiring
data for a VOI  10  10  10 mm3 shimmed to 1 Hz
linewidth at both ﬁeld strengths, yielded a ratio of mea-
sured SNR of 2.3, which was in line with theoretical pre-
dictions. However, other studies reported a supralinear
increase in SNR with ﬁeld strength for a localized volume
as well (22).
Despite a reduction in scan time by a factor of two at 7T,
the precision of quantiﬁcation was increased for 12 metab-
olites using the 7T spectra as judged from the mean CRLB
(Table 1), which can be attributed to the increased SNR
and spectral resolution at the higher ﬁeld strength (23).
The latter also allowed the improved detection of Lac with
CRLB below 20% that is quite remarkable given the low
concentration of Lac in the brain under normal conditions
(24). The fact that Glc was only quantiﬁed at 3T can be
explained by its generally complex multiplet pattern col-
lapsing at 3T into two multiplets centered at 3.43 ppm and
3.8 ppm (25) (see Fig. 5a and b), thus somewhat simplify-
ing detection of Glc at this ﬁeld strength.
In general, metabolite concentrations determined at the
two ﬁelds were in good agreement. Larger relative differ-
ences (
30%) were only observed for PCr, GABA, Gln, and
Scyllo, of which, especially GABA, Gln, and Scyllo, are
metabolites of low concentration. The quantiﬁcation of
Gln, Tau, and Gln	Glu was clearly more reliable at 7T
indicated by the two- to three-fold reduced CRLBs. Simi-
larly, the absolute concentration for GABA measured at 7T
(1.3 mmol/kg) approached the literature value of
1 mmol/kg (25).
The metabolite concentrations determined at 7T (see
Table 1) were in good agreement with values reported in
(26), where ultrashort TE STEAM data acquired at 7T from
VOIs of the same size (8 ml) outside and inside the visual
cortex were used for quantiﬁcation. Different were the
concentrations for Asp (different by 66%), myo-Inositol
(Ins) (18%), and phosphorylethanolamine (PE) (52%),
though CRLBs for these metabolites were slightly (Ins) or
substantially (Asp and PE) reduced in the present study. In
addition, the estimated concentration of Tau (Table 1) was
also found previously (8).
At 3T, only a limited number of studies quantifying a
substantial number of metabolites have been reported.
Comparing the results presented here to those obtained
with SVS (27; Table 4 therein) assuming 8 mM of total
creatine (tCr  Cr 	 PCr), it is noted that concentrations
for NAA, NAA	N-acetylaspartylglutamate (NAAG), Glu,
Ins, Asp, and Scyllo were in excellent agreement,
while concentrations for NAAG, glycerophosphocholine
(GPC) 	 phosphocholine (PCho)  total choline (tCho),
glutathione (GSH), PE, and Tau were larger in the previous
study (27). However, the number of quantiﬁed metabolites
was higher in the present study, and the corresponding
CRLBs for all of these metabolites were reduced for the 3T
results of this study (Table 1) compared to those reported
previously (27). Considering the list of metabolite concen-
trations for GM that were obtained in various 3T and 4T
studies (11), it is observed that for tCho, tCr, and NAA the
values were in excellent agreement with the 3T results
reported here. For Glu and Ins, the results obtained in this
study are slightly smaller, though still within the same
range of concentrations.
The ability to reliably quantify a large set of metabolites
should enhance clinical application of MRS. In this con-
text it is important to note that the use of a TEM volume
coil at 3T did not result in signiﬁcantly reduced data
quality (Fig. 4). In particular, the absence of lipid contam-
inations in the spectrum indicated the effectiveness of the
applied OVS scheme. Using a volume coil introduces
greater ﬂexibility for examining different anatomical re-
gions. Among the many possible clinical applications in-
clude the quantiﬁcation of GSH, which is believed to be
reduced in schizophrenic patients (28), but has been dif-
ﬁcult to measure with sufﬁcient precision.
In conclusion, a large number of metabolites can be
reliably quantiﬁed from single-voxel spectra acquired on
clinical scanners in human brain at 3T and 7T using the
SPECIAL technique with an echo time on the order of a
few milliseconds. The higher SNR and increased spectral
resolution at 7T were shown to lead to substantial im-
provements in precision and accuracy even at a reduced
scan time. The proposed localization method features the
beneﬁts of ultrashort echo time and high signal intensity
and is likely advantageous in situations of RF inhomoge-
neity and peak RF power limitations such as often encoun-
tered at high B0 ﬁelds; e.g., 7T in humans.
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